The present disclosure relates to compounds, compositions and methods for the treatment of hepatitis C virus (HCV) infection. Also disclosed are pharmaceutical compositions containing such compounds and methods for using these compounds in the treatment of HCV infection.

 
Web www.patentalert.com

< Hepatitis C inhibitor tri-peptides

< Hepatitis C virus variants

> Enhancement of the immune response for vaccine and gene therapy applications

> Macrocyclic peptides active against the hepatitis C virus
~ 00619